Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.
Jamieson, David a; Cresti, Nicola a,b; Bray, Johanne a,b; Sludden, Julieann a; Griffin, Melanie J. a; Hawsawi, Nahed M. a; Famie, Eve a; Mould, Emily V.A. a; Verrill, Mark W. b; May, Felicity E.B. a; Boddy, Alan V. a
[Article] Pharmacogenetics and Genomics. 21(12):808-819, December 2011.

(Format: HTML, PDF)